Jonathan Feldschuh

Jonathan is the co-inventor of the BVA-100 and associated patents. He is responsible for algorithmic design, statistical analysis and for patent applications for the next generation blood volume analyzer and its utility across diverse surgical and medical conditions. Jonathan has developed black-box trading and analytical systems for Wall Street firms such as Morgan Stanley, Millennium Partners, and Shearson Lehman and served in the past as chief quantitative officer for Aristarc Capital and as the CEO of Outseeker, a data-driven technology startup. Jonathan has an A.B. in physics summa cum laude from Harvard.